THE KPM GROUP DC LLC

Lobbying for SEBELA PHARMACEUTICALS · Developing therapies for gastrointestinal diseases and women's health

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Georgia · House · Senate · $40,000.00 income · posted Oct 7, 2025

Lobbying activity 1

Health Issues

Requesting CMS change guidance on Bowel Prep Coverage for Screening Colonoscopies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.